IMMUCELL CORP /DE/ financial data

Symbol
ICCC on Nasdaq
Location
Portland, ME
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 388% % 42%
Quick Ratio 195% % 14%
Debt-to-equity 58% % -22.12%
Return On Equity 8% %
Return On Assets 5.1% %
Operating Margin 6.1% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,045,851 shares 1.5%
Common Stock, Shares, Outstanding 9,045,851 shares 2.4%
Entity Public Float $30,634,000 USD -1.7%
Common Stock, Value, Issued $910,563 USD 2.4%
Weighted Average Number of Shares Outstanding, Basic 9,045,851 shares 11%
Weighted Average Number of Shares Outstanding, Diluted 9,045,851 shares 11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $28,274,756 USD 18%
Revenue from Contract with Customer, Excluding Assessed Tax $5,506,122 USD -8.41%
Cost of Revenue $3,143,024 USD -29.02%
Research and Development Expense $3,102,410 USD -25.16%
Selling and Marketing Expense $3,308,182 USD 0.2%
General and Administrative Expense $2,627,392 USD 20%
Operating Income (Loss) $2,328,655 USD
Nonoperating Income (Expense) $9,315 USD -23.84%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,337,970 USD 81%
Income Tax Expense (Benefit) $14,300 USD 166%
Net Income (Loss) Attributable to Parent $2,323,670 USD 80%
Earnings Per Share, Basic 0 USD/shares 78%
Earnings Per Share, Diluted 0 USD/shares 78%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,886,198 USD
Accounts Receivable, after Allowance for Credit Loss, Current $2,554,766 USD 11%
Inventory, Net $9,802,005 USD 31%
Assets, Current $16,825,178 USD 21%
Property, Plant and Equipment, Net $24,340,740 USD -5.73%
Operating Lease, Right-of-Use Asset $4,419,527 USD -3.77%
Goodwill $95,557 USD 0%
Other Assets, Noncurrent $44,345 USD 53%
Assets $45,730,123 USD 2.9%
Liabilities, Current $3,997,888 USD -10.48%
Long-term Debt and Lease Obligation $8,653,064 USD -14.91%
Operating Lease, Liability, Noncurrent $4,032,680 USD -2.79%
Liabilities $15,929,282 USD -11.69%
Retained Earnings (Accumulated Deficit) $-12,354,611 USD 16%
Stockholders' Equity Attributable to Parent $29,800,841 USD 13%
Liabilities and Equity $45,730,123 USD 2.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,573,836 USD 276%
Net Cash Provided by (Used in) Financing Activities $-403,647 USD -10.12%
Net Cash Provided by (Used in) Investing Activities $-329,050 USD -367.69%
Common Stock, Shares Authorized 15,000,000 shares 0%
Common Stock, Shares, Issued 9,105,622 shares 2.4%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,998,494 USD 353%
Interest Paid, Excluding Capitalized Interest, Operating Activities $117,857 USD -13.63%
Deferred Tax Assets, Valuation Allowance $4,593,989 USD 14%
Operating Lease, Liability $4,115,122 USD -11.13%
Depreciation $2,678,032 USD 0.33%
Payments to Acquire Property, Plant, and Equipment $329,050 USD 368%
Lessee, Operating Lease, Liability, to be Paid $7,048,758 USD -10.5%
Property, Plant and Equipment, Gross $45,939,840 USD -0.57%
Operating Lease, Liability, Current $82,442 USD -82.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $353,812 USD 1.2%
Lessee, Operating Lease, Liability, to be Paid, Year One $346,874 USD -51.26%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,933,636 USD -9.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three $360,885 USD 1.2%
Deferred Tax Assets, Operating Loss Carryforwards $3,705,923 USD -0.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four $368,397 USD 1.2%
Operating Lease, Payments $747,689 USD 36%
Amortization of Intangible Assets $19,104 USD 0%
Depreciation, Depletion and Amortization $708,667 USD 3.3%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $260,953 USD -26.98%
Interest Expense $584,951 USD 40%